These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8028539)

  • 21. De novo HCV infection among dialysis patients: a prospective study by HCV core antigen ELISA assay.
    Fabrizi F; de Vecchi AF; Como G; Lunghi G; Martin P
    Aliment Pharmacol Ther; 2005 Apr; 21(7):861-9. PubMed ID: 15801921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vertical transmission of HCV infection: prospective study in infants born to HIV-1 seronegative women.
    Di Domenico C; Di Giacomo C; Marinucci G; Di Paolo A
    Ig Sanita Pubbl; 2006; 62(2):129-42. PubMed ID: 17211953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance of hepatitis C virus (HCV) antibody test systems in relation to HCV-RNA detection in the diagnosis of HCV infection.
    Krarup HB; Jacobsen SE; Varming K; Drewes AM; Madsen PH
    Dan Med Bull; 1998 Feb; 45(1):89-91. PubMed ID: 9504268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the available anti-HCV antibody detection tests and RT-PCR assay in the diagnosis of hepatitis C virus infection.
    Tashkandy MA; Khodari YA; Ibrahim AM; Dhafar KO; Gazzaz ZJ; Azab BA
    Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):523-31. PubMed ID: 17951937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of hepatitis C virus antibodies and RNA among medicolegal autopsy cases in Northern France.
    Lazrek M; Goffard A; Schanen C; Karquel C; Bocket L; Lion G; Devaux M; Hedouin V; Gosset D; Hober D
    Diagn Microbiol Infect Dis; 2006 May; 55(1):55-8. PubMed ID: 16490339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis and their relationship to viral replication and liver disease.
    Chemello L; Cavalletto D; Pontisso P; Bortolotti F; Donada C; Donadon V; Frezza M; Casarin P; Alberti A
    Hepatology; 1993 Feb; 17(2):179-82. PubMed ID: 8381380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency and chronology of occurrence of anti-HCV in non-A non-B post-transfusional hepatitis.
    Barcena R; Martín-de-Argila C; Ulibarrena C; Erdozain JC; Gil Grande LA; Mateos M
    Rev Esp Enferm Dig; 1993 Oct; 84(4):245-8, 241-4. PubMed ID: 8292436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of hepatitis C virus isolates using molecular and serological typing methods.
    Cretel E; Gallian P; Obadia Y; Rousseau S; de Micco P; de Lamballerie X
    Acta Virol; 1997 Oct; 41(5):269-75. PubMed ID: 9607080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the patients with low levels of anti-HCV positivity].
    Zer Y; Karaoğlan I; Ciçek H; Karağoz ID; Sağlam M
    Mikrobiyol Bul; 2009 Jan; 43(1):133-9. PubMed ID: 19334390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type-specific antibody for hepatitis C virus detected by use of NS-4 peptide and hepatitis C virus genome in Korea.
    Son HC; Yoon MS; Kim YJ; Kim IH; Kim YS
    Rinsho Byori; 2002 May; 50(5):533-40. PubMed ID: 12078055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The status and significance of mother-to-infant transmission of hepatitis C virus determined by nested polymerase chain reaction].
    Hao F; Li M; Thaler MM; Chen G
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun; 11(2):127-9. PubMed ID: 15619816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical value of the detection of hepatitis C virus core antigen].
    Lu YC; Jiang ZY; Kuang YL; Chen WS; Tan YZ; Li DR
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul; 23(7):635-7. PubMed ID: 17618587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis of chronic hepatitis C: comparison of immunoassays and the polymerase chain reaction.
    Silva AE; Hosein B; Boyle RW; Fang CT; Shindo M; Waggoner JG; Hoofnagle JH; Di Bisceglie AM
    Am J Gastroenterol; 1994 Apr; 89(4):493-6. PubMed ID: 8147348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcome of screening for hepatitis C virus infection based on risk factors.
    Mallette C; Flynn MA; Promrat K
    Am J Gastroenterol; 2008 Jan; 103(1):131-7. PubMed ID: 17894850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A critical evaluation of hepatitis C testing of cadaveric corneal donors.
    Laycock KA; Essary LR; Delaney S; Kuhns MC; Pepose JS
    Cornea; 1997 Mar; 16(2):146-50. PubMed ID: 9071526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis C virus markers and de novo liver disease after transplantation: a prospective study.
    Franco A; Muñoz C; Jimenez L; Verdejo F; Arenas D; Olivares J
    Transplant Proc; 1995 Aug; 27(4):2260-1. PubMed ID: 7544499
    [No Abstract]   [Full Text] [Related]  

  • 37. Detection of hepatitis C virus by polymerase chain reaction and recombinant immunoblot assay 3.0 in porphyria cutanea tarda.
    Andreone P; Cursaro C; Gramenzi A; Guidetti MS; Bardazzi F; Tosti A; Miniero R
    Hepatology; 1995 Jun; 21(6):1754-5. PubMed ID: 7539399
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-hepatitis C virus antibodies in monoclonal gammopathy: an appraisal using the second generation tests.
    Marson P; Vicarioto M; De Silvestro G; Tenderini ML; Nardo G; Ongaro G
    Haematologica; 1992; 77(2):188. PubMed ID: 1328000
    [No Abstract]   [Full Text] [Related]  

  • 39. Significance of NS3 and NS5 antigens in screening for HCV antibody.
    Goffin E; Pirson Y; Cornu C; Jadoul M; van Ypersele de Strihou C
    Lancet; 1994 Apr; 343(8901):854. PubMed ID: 7511196
    [No Abstract]   [Full Text] [Related]  

  • 40. Should the c100 antigen be removed from HCV antibody assays?
    Zaaijer HL; Cuypers HT; Reesink HW; Lelie PN
    Vox Sang; 1994; 66(2):150. PubMed ID: 7514326
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.